MEK114267, A Phase III Randomized, Open-Label Study Comp

  • Dudek, Arkadiusz Z (PI)

Project: Research project

Project Details

Description

MEK114267, A Phase III Randomized, Open-Label Study Comparing GSK1120212 to Chemotherapy in Subjects with Advanced or Metastatic BRAF V600E/K Mutation Positive Melanoma
StatusFinished
Effective start/end date9/28/1010/30/12

Funding

  • GlaxoSmithKline

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.